|
- 2019
Efficacy and Safety of Octagam? in Patients With Chronic Inflammatory Demyelinating PolyneuropathyDOI: 10.1007/s40120-019-0132-5 Keywords: Chronic inflammatory demyelinating polyneuropathy, Immunoglobulins, Immunotherapy, Octagam?, Peripheral nervous system disease Abstract: Octapharma, France SAS
|